Totaligent

Totaligent, Inc. and GloMed Solutions LLC signed a binding letter of intent to form a joint venture integrating Totaligent's Aetherium Medical platform with GloMed's operations in Japan and APAC. The JV is expected to close within four weeks, with Totaligent holding strategic control via three board seats.